The @PanFabBoston team started its work about a year ago in response to #COVID19 related shortages of #PPE at @BrighamWomens. A primary goal at PanFab was to engineer solutions to the PPE crisis in real time using technology like #3Dprinting. 1/
Does private equity ownership impact wait times in derm? Our study on Insurance Acceptance & Wait Times in Derm in @JAMADerm led by Andrew Creadore w/support frm @SheenaDesai3, @sara_j_li, @CJoyceBiostats, @JackResneckMD &senior author @KiraSeiger. 🧵1/9 https://t.co/F2L9UqRXfp
Big thanks to Dr. Fauci and our panelists for an illuminating @harvardmed Grand Rounds this morning on the Public Health and Scientific Challenges of #COVID__19, who cautioned us about underestimating the potential of the #pandemic. Watch here:
https://t.co/INh0CIyZjf
Increasing the proportion of SARS-CoV-2 infections that are asymptomatic with the simple public health measure of universal masking might help make the infection less deadly and increase population-level immunity without severe illnesses and deaths. #COVID19#SARSCoV2
Lack of trust undermines our ability to work together to fight against Covid. That's why we must base decisions on science and insist on complete transparency on data and process.
Our @PanFabBoston work featured in @harvardmed News & Research highlighting the power of interdisciplinary collaboration in developing innovative solutions to solve PPE shortages.
@bwhdermatology @BrighamWomens@HarvardMIT_CRS
@HiTSatHarvard
Very proud to be part of the team doing this work- so many factors to consider when deploying disinfecting products at your institution. Thanks @PanFabBoston
🚨NEW from the PanFab Team!🚨
Considerations for the Selection and Use of Disinfectants Against #SARSCoV2 in a Healthcare Setting https://t.co/wAGW7UNeTQ via @IDSAInfo#OFID
If an asymptomatic contact tests positive, their contacts can be identified, warned, and quarantined. Not testing asymptomatic contacts allows Covid to spread. The CDC guidance is indefensible. No matter who wrote it and got it posted on the CDC site, it needs to be changed.
After starting as President and CEO of @BeebeHealthcare in March, David A. Tam, MD, FACHE, was promptly dealing with COVID-19 challenges. Explore what David has learned in his first 100 days through our new COVID-19 Stories section of the digital edition of Healthcare Executive.